See also this year's filing and all EDGAR filings for this company.
PDF Report 0001435049_2021_Chinook_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001435049, Chinook Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 254,081,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 50,137,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 124,784,000 |
| 4 | LiabilitiesCurrent | 22,809,000 |
| 5 | LiabilitiesNoncurrent | 39,614,000 |
| 6 | remainder_Liabilities | 31,957,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,281,943 |
| 9 | ResearchAndDevelopmentExpense | 9,537,090 |
| 10 | remainder_Expenses | 22,894,534 |
| 11 | remainder_Revenues | 2,617,292 |
| 12 | remainder_NetIncome | -4,387,887 |
| 13 | remainder_ComprehensiveNetIncome | -209,721 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 429,002,000 |
| 1 | Liabilities | 94,380,000 |
| 2 | Expenses | 46,713,567 |
| 3 | Revenues | 2,617,292 |
| 4 | StockholdersEquity | 334,622,000 |
| 5 | NetIncome | -48,484,162 |
| 6 | ComprehensiveNetIncome | -48,589,022 |
| 7 | BaseVar | 288,655,234 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.60 |
| 9 | EconomicCapitalRatio | 3.42 |